Trials / Completed
CompletedNCT01941901
Calcium Electroporation for Treatment of Cutaneous Metastases
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Herlev Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.
Detailed description
Double-blinded phase II clinical study. We will compare the effect of calcium electroporation for the treatment of cutaneous metastases with standard treatment: electrochemotherapy with intratumoral injection of bleomycin. Separate randomisation will be performed and the lesions will be treated with either intratumoral injection of calcium or bleomycin. It is a once only treatment and the patients will be followed up for 6 months. It is a non-inferiority study and we accept a difference in response on 15%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium electroporation | Intratumoral injection, once only treatment. |
| DRUG | Electrochemotherapy with bleomycin | Intratumoral injection, once only treatment |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2016-09-01
- Completion
- 2017-01-23
- First posted
- 2013-09-13
- Last updated
- 2019-11-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01941901. Inclusion in this directory is not an endorsement.